JP2022529182A5 - - Google Patents
Info
- Publication number
- JP2022529182A5 JP2022529182A5 JP2021562045A JP2021562045A JP2022529182A5 JP 2022529182 A5 JP2022529182 A5 JP 2022529182A5 JP 2021562045 A JP2021562045 A JP 2021562045A JP 2021562045 A JP2021562045 A JP 2021562045A JP 2022529182 A5 JP2022529182 A5 JP 2022529182A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- pharmaceutically acceptable
- levetiracetam
- acceptable salt
- therapeutic combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025133394A JP2025166119A (ja) | 2019-04-18 | 2025-08-08 | 治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835707P | 2019-04-18 | 2019-04-18 | |
| US62/835,707 | 2019-04-18 | ||
| US201962926130P | 2019-10-25 | 2019-10-25 | |
| US62/926,130 | 2019-10-25 | ||
| PCT/US2020/028777 WO2020214960A1 (en) | 2019-04-18 | 2020-04-17 | Therapeutic combinations, liquid pharmaceutical compositions, kits for their preparation, and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133394A Division JP2025166119A (ja) | 2019-04-18 | 2025-08-08 | 治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529182A JP2022529182A (ja) | 2022-06-17 |
| JP2022529182A5 true JP2022529182A5 (cg-RX-API-DMAC10.html) | 2023-04-25 |
| JP7730548B2 JP7730548B2 (ja) | 2025-08-28 |
Family
ID=72837945
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562045A Active JP7730548B2 (ja) | 2019-04-18 | 2020-04-17 | 治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法 |
| JP2025133394A Pending JP2025166119A (ja) | 2019-04-18 | 2025-08-08 | 治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025133394A Pending JP2025166119A (ja) | 2019-04-18 | 2025-08-08 | 治療用組合せ、液状の薬学的組成物、それらの調製のためのキット、およびこれらの使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220193028A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3955905A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7730548B2 (cg-RX-API-DMAC10.html) |
| MA (1) | MA55726A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020214960A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240423953A1 (en) * | 2021-01-26 | 2024-12-26 | The Regents Of The University Of California | Methods and compositions for targeting sv2 proteins for immune regulation |
| CN117771240A (zh) * | 2023-12-05 | 2024-03-29 | 中国人民解放军海军军医大学 | 一种左乙拉西坦在制备减肥药物中的应用 |
| WO2025212556A1 (en) * | 2024-04-03 | 2025-10-09 | Prevep, Inc. | Formulations comprising seletracetam and methods of use |
| WO2025221463A1 (en) * | 2024-04-19 | 2025-10-23 | Prevep, Inc. | Pharmaceutical compositions comprising atorvastatin, or a salt thereof, and a liquid carrier |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003175091A (ja) * | 2001-10-03 | 2003-06-24 | Nipro Corp | 複室容器製剤 |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
| DE602004023510D1 (de) * | 2003-07-15 | 2009-11-19 | Ono Pharmaceutical Co | Verzweigte carbonsäureverbindung und deren verwendung |
| US7611728B2 (en) * | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
| EP1718308A4 (en) * | 2004-02-11 | 2007-07-18 | Painceptor Pharma Corp | PROCESS FOR MODULATING NEUROTROPHINE-MEDIATED ACTIVITY |
| US20090239942A1 (en) * | 2006-09-15 | 2009-09-24 | Cloyd James C | Topiramate Compositions and Methods of Making and Using the Same |
| EP2363113B1 (en) * | 2006-12-04 | 2017-08-02 | Supernus Pharmaceuticals, Inc. | Enhanced immediate release formulations of topiramate |
| AU2009274571A1 (en) * | 2008-07-23 | 2010-01-28 | Massachusetts Institute Of Technology | Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival |
| MX2011001384A (es) * | 2008-08-06 | 2011-09-27 | Gosforth Ct Holdings Pty Ltd | Composiciones y metodos para tratar trastornos psiquiatricos. |
| US20140239525A1 (en) * | 2011-06-17 | 2014-08-28 | Board Of Regents, University Of Texas System | Inhalable pharmaceutical compositions |
| WO2013061161A2 (en) * | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
| EP2705843A1 (en) * | 2012-09-05 | 2014-03-12 | Pharnext | Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesis |
| EA034167B8 (ru) * | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| UA125747C2 (uk) * | 2015-09-01 | 2022-06-01 | Фьост Вейв Байо, Інк. | Способи та композиції для лікування станів, пов'язаних із аномальною запальною відповіддю |
| JP2020513772A (ja) * | 2016-12-28 | 2020-05-21 | エクスペシコール エルエルシー | 神経変性障害の非ヒト動物モデル |
| CN108379588B (zh) * | 2018-03-05 | 2024-07-02 | 合肥合源药业有限公司 | 托吡酯组合物 |
-
2020
- 2020-04-17 US US17/603,707 patent/US20220193028A1/en active Pending
- 2020-04-17 EP EP20790454.1A patent/EP3955905A4/en active Pending
- 2020-04-17 WO PCT/US2020/028777 patent/WO2020214960A1/en not_active Ceased
- 2020-04-17 JP JP2021562045A patent/JP7730548B2/ja active Active
- 2020-04-17 MA MA055726A patent/MA55726A/fr unknown
-
2025
- 2025-08-08 JP JP2025133394A patent/JP2025166119A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2484815C2 (ru) | Продолжительное 24-часовое введение в кишечник леводопа/карбидопа | |
| TWI618539B (zh) | 無刺激性眼用聚乙烯吡咯啶酮-碘組成物 | |
| Weinbroum et al. | Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain | |
| TWI405576B (zh) | 疼痛疾病治療劑 | |
| US20080089861A1 (en) | Combination therapy for treatment of demyelinating conditions | |
| JP2018501299A5 (cg-RX-API-DMAC10.html) | ||
| US20050245460A1 (en) | Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders | |
| CN1720025A (zh) | 加巴喷丁片剂及其制备 | |
| JP2020524702A (ja) | 免疫応答を調節するgabaの能力の強化 | |
| RS64481B1 (sr) | Lečenje alchajmerove bolesti kod posebne populacije pacijenata | |
| US10076506B2 (en) | Baclofen formulations and methods for making same | |
| US20230066347A1 (en) | Ketamine treatment for amyotrophic lateral sclerosis | |
| JP2021001221A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| US6372792B1 (en) | Method for treating anxiety, anxiety disorders and insomnia | |
| CZ111897A3 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| WO2023155837A1 (zh) | 具有镇痛和/或止痒功能的药物组合物及其用途 | |
| RU2377983C2 (ru) | Препарат l-триптофана, содержащий карбидопу/бенсеразид | |
| Yaseen et al. | Analgesic effects of magnesium sulphate in patients undergoing laparoscopic cholecystectomy | |
| JP2025505578A5 (cg-RX-API-DMAC10.html) | ||
| JP2005531594A5 (ja) | 慢性痛の治療用トリプルモノアミン再取り込み阻害剤 | |
| CN103012192B (zh) | 一种新型乙酰谷酰胺化合物及其药物组合物 | |
| WO2022037006A1 (zh) | 一种止痛止痒药物组合物及其应用方法 | |
| CN1137686C (zh) | 椎管狭窄的治疗药 | |
| HK40069667A (en) | Pharmaceutical composition with analgesic and/or antipruritic function and uses thereof | |
| CN1929830A (zh) | Nmda受体拮抗剂联合抗癫痫药物治疗癫痫症和其他中枢神经系统疾病的组合物和方法 |